Trial Profile

Evaluation of Naltrexone as a Treatment for Self-Injurious Behavior

Status: Withdrawn prior to enrolment

Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Naltrexone (Primary)
Indications Self-injurious behaviour
Focus Therapeutic Use
Acronyms NTX-SIB

Most Recent Events

31 Oct 2017 Planned End Date changed from 1 Sep 2018 to 4 Jan 2017.
31 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 30 Jun 2015.
31 Oct 2017 Planned initiation date changed from 1 Sep 2016 to 22 Feb 2014.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com